6 May 2025

A new experimental drug improves motor function and prolongs life in an ALS model.

The MP-010 molecule, developed by Miramoon Pharma, acts on ryanodine receptors, opening a new therapeutic avenue for treating ALS, according to a study led by researchers from CIBERNED and several research institutes, including the IIS Aragón.
2 May 2025

Conference 'Gambling, a Public Health Problem', May 9

The CaixaForum Zaragoza Auditorium will host a conference addressing gambling as a public health issue. The event will also present two innovative prevention projects, GAMBL-OUT and GAMBL-HID, led by researchers from the IIS Aragón.
30 April 2025

'I HumanizAR and CuidAR Awards for Aragon': recognition of the humanization of healthcare

The Government of Aragon, in collaboration with Roche, will award innovative initiatives in hospitals and healthcare centers that promote more humane and high-quality care. Projects can be submitted until June 24, 2025.
30 April 2025

José María Marín: “It’s essential to know English, travel, and experience the work of other researchers firsthand.”

In this interview, the IIS Aragón researcher talks about his work leading the 'Precision Medicine in Respiratory Diseases (PRES)' group (GIIS041) and his most notable projects.
29 April 2025

Mycotherapy: Could a fungus be the key to curing cancer?

Fungi generate compounds with valuable medicinal properties that have led to the development of drugs such as antibiotics, statins, and immunological treatments. Their use in therapies for various types of cancer is currently being studied.